Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients
- 1 January 2017
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 71, 70-79
- https://doi.org/10.1016/j.ejca.2016.10.029
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Canadian Integrative Oncology Research Priorities: Results of a Consensus-Building ProcessCurrent Oncology, 2013
- A Systematic Review of Integrative Oncology ProgramsCurrent Oncology, 2012
- Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer centerZeitschrift für Krebsforschung und Klinische Onkologie, 2012
- A Systematic Literature Review of Complementary and Alternative Medicine Prevalence in EUComplementary Medicine Research, 2012
- How Many Cancer Patients Use Complementary and Alternative MedicineIntegrative Cancer Therapies, 2011
- Dietary Supplement Use in Adult Cancer SurvivorsOncology Nursing Forum, 2009
- Herbal use among cancer patients during palliative or curative chemotherapy treatment in NorwaySupportive Care in Cancer, 2008
- Lesson From Comparison of CAM Use by Women With Female-Specific Cancers to Others: It's Time to Focus on Interaction Risks With CAM TherapiesIntegrative Cancer Therapies, 2007
- Use of complementary and alternative medicine in cancer patients: a European surveyAnnals of Oncology, 2005
- Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasisEuropean Journal of Cancer, 2004